Navigation Links
Boston Scientific Announces Results for First Quarter Ended March 31, 2011
Date:4/20/2011

ause such differences include, among other things: future economic, competitive, reimbursement and regulatory conditions; new product introductions and the market acceptance of those products; the market for our products, including the U.S. CRM market;  pricing environment; procedural volumes; clinical trial results; demographic trends; intellectual property rights and related and other litigation; financial market conditions; the effect of our goodwill impairment charges and our restructuring initiatives; integration of acquired companies; and future business decisions made by us and our competitors. New risks and uncertainties may arise from time to time and are difficult to predict. All of these factors are difficult or impossible to predict accurately and many of them are beyond our control.  For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item IA - Risk Factors in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A - Risk Factors in Quarterly Reports on Form 10-Q we have filed or will file hereafter.  We disclaim any intention or obligation to publicly update or revise any forward-looking statement to reflect any change in our expectations or in events, conditions, or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements.  This cautionary statement is applicable to all forward-looking statements contained in this press release.

Use of Non-GAAP Financial InformationA reconciliation of the Company's non-GAAP financial measures to the corresponding GAAP measures, and an explanation of the Company's use of these non-GAAP financial measures, is included in the exhibits attached to this press release. CONTACT:

Erik Kopp508-650-8660 (office)
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Dainippon Sumitomo Pharma Co., Ltd. and Boston Biomedical, Inc. Enter Strategic Partnership on Anti-Cancer Drugs Targeting Cancer Stem Cells
2. Boston Scientific Begins International Clinical Trial Enrollment for INNOVA™ Self-Expanding Bare-Metal Stent System
3. Boston Scientific ION™ Platinum Chromium Stent System Demonstrates Strong Performance in Analysis of PERSEUS and TAXUS ATLAS Clinical Trial Data
4. Hologic, Hospira, Boston Scientific, Allergan to Participate in Leading Medical Device Manufacturing Symposium
5. Boston Scientific Announces Its ACC 2011 Schedule
6. Boston Scientific Receives FDA Approval of New Clik(TM) Anchor for Precision Plus(TM) Spinal Cord Stimulator System
7. Boston Scientific to Webcast Analyst Event
8. Boston Scientific to Present at Barclays Capital 2011 Global Healthcare Conference
9. Boston Scientific Announces European Approval and Launch of OMEGA™ Platinum Chromium Stent System
10. Unilife to Present at the 31st Annual Cowen Health Care Conference on Wednesday, March 9, 2011 in Boston
11. Boston Scientific Strengthens Structural Heart Product Portfolio By Completing Acquisition of Atritech
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/jq34zf/investigation ... Report on China,s Tobramycin Market, 2010-2019" report to ... whose eye drop and ointment are the most common ... inflammation caused by eye infection. Currently, dozens of enterprises ... produce tobramycin, among which the Top 5 are s.a. ...
(Date:8/28/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/rktnl9/investigation ... "Investigation Report on China,s Insulin Aspart Market, 2010-2019" ... by Novo Nordisk, insulin aspart (under the trade ... the treatment of diabetes. Compared with human insulin, ... starts working fast and reports higher peak of ...
(Date:8/28/2015)... , Aug. 28, 2015  IP Shakti, LLC, today announced ... Logo - ... "Our new corporate identity signifies our transformation into a ... predictive analytics platform for patent claim validity." ... of the proprietary AIA Shield™ platform, the Company commenced a ...
Breaking Medicine Technology:Investigation Report on China's Tobramycin Market, 2015-2019 2China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2IP Shakti, LLC Changes Company Name to Prediqtus, LLC 2
... CALGARY, June 20, 2007 /PRNewswire-FirstCall/ - SemBioSys,Genetics ... portfolio of,therapeutic proteins for metabolic and cardiovascular ... a scientific poster and,abstract at the 67th ... in Chicago. The Company's poster will disclose,recent ...
... Follow,Presentation, DANBURY, Conn., June 20, 2007 /PRNewswire-FirstCall/ -- ... of its,leading product candidate, VIAject(TM), at the 67th ... held in,Chicago, June 22 through June 26. , ... place on June 22,from 4:15 - 6:15pm CST, ...
Cached Medicine Technology:SemBioSys to present new data at American Diabetes Association,annual meeting 2SemBioSys to present new data at American Diabetes Association,annual meeting 3Biodel Inc. to Present VIAject Clinical Progress at the 2007,American Diabetes Association Meeting 2Biodel Inc. to Present VIAject Clinical Progress at the 2007,American Diabetes Association Meeting 3
(Date:8/29/2015)... ... , ... Rio Salado College President Chris Bustamante announced on Aug. ... Strategic Initiatives and Information Services. O’Shea, who has served Rio Salado for the last ... impact through innovative technologies and strategies. , “I am very proud to be able ...
(Date:8/29/2015)... ... August 29, 2015 , ... It can be ... against dribbled urine and sweat. "In order to prevent these problems, I conceived ... ACCESS DRYNESS ENHANCED MEN'S UNDERGARMENT provides optimal support for a male’s crotch. It ...
(Date:8/29/2015)... ... August 29, 2015 , ... ProDrop Particles includes over 40 ... contains 15 seconds of unique footage that users can shrink and stretch in the ... and more. Users can customize color, brightness, scale, speed, range, and flare attributes with ...
(Date:8/28/2015)... AZ (PRWEB) , ... August 29, 2015 , ... ... reinvent higher learning and the student experience as part of the EDUCAUSE - Next ... Gates Foundation . , This is the third Breakthrough Models Incubator hosted ...
(Date:8/28/2015)... ... 2015 , ... An article published August 19th by the LA ... through to open a pizzeria in Westchester. Mr. LaRocco was aware from opening prior ... but the current process, having already gone on for over a year, is taking ...
Breaking Medicine News(10 mins):Health News:Rio Salado College Appoints New Vice President of Strategic Initiatives and Information Services 2Health News:Modified Men’s Underwear Promote More Comfort and Hygiene - Designed by InventHelp Client (LGI-1968) 2Health News:FCPX Effects Developer, Pixel Film Studios, Releases ProDrop Particles. 2Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 2Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 3Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 4Health News:Article on Building Approval Process for LA Business Highlights the Need for a Bridge Between Businesses and City Officials, says Fire Protection Group Inc. 2
... claimed that 'Harry Potter is dead'. ,Hackers have ... the title of JK Rowling's up-coming book, out on July ... works by infecting USB memory drives plugged into computers where ... hop between different computers each time the device is inserted. ...
... Inc. (NYSE: BAY) and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) ... for Nexavar(R) (sorafenib) tablets has been submitted to ... treatment of patients with hepatocellular carcinoma (HCC), the most ... currently approved in more than 50 countries for the ...
... found that Exercise has a similar effect to antidepressants ... ,In a series of scientific reports, she has ... exercise can be a form of therapy for depression ... an SSRI drug. ,The experiment studies were ...
... Sanofi-Aventis said Friday it had withdrawn an application for regulatory ... ,A panel of experts from the US ... dieting treatment, referred to as rimonabant by the company, was ... ,"Sanofi-Aventis will work towards submitting the rimonabant file ...
... deliver his wife's baby after doctors refused to touch the ... husband told India's NDTV news channel he carried out the ... the northern state of Uttar Pradesh shouted instructions from a ... line and asked me to pull out the baby and ...
... Benoits son suffered from a rare mental disability called Fragile ... argument with his wife Nancy on who should take care ... them and went on to commit suicide. ,An ... ''I think it's fair to say that the subject of ...
Cached Medicine News:Health News:Bayer and Onyx Submit Supplemental New Drug Application for Nexavar to Treat Liver Cancer 2Health News:Indian Doctors Refuse to Help HIV-positive Woman Deliver: Report 2Health News:Benoits Son Suffered from Fragile X Syndrome, a Rare Mental Disability 2
... a complete physician preference card system as ... for all the supply management requirements of ... system combined with a broad array of ... cart and operating suite supply and charge ...
Easy to Use manual vacuum system features a pumping mechanism that can be operated with one hand....
... Total TTC® is a complete ophthalmic system ... Color coded function modes with clear LED ... assures an easy to operate and user ... footswitch provides the surgeon complete control of ...
The D.O.R.C. Silicone Oil is an ultra purified silicone oil which leads a maximum interfacial tension and minimizes interactions between tissues, cells and endo-tamponades media. (Sterile, 10 ml.)...
Medicine Products: